The FDA said it has authorized Labcorp’s combination Covid-19, flu, and RSV test for direct-to-consumer use, the first such test to be accessible without a prescription.

• Authorized Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infection consistent with Covid-19
• First direct-to-consumer (non-prescription) multi-analyte Covid-19 test authorized by FDA
• NOTE: LabCorp Launches Combined Test for Covid-19, Flu and RSV

To view the source of this information click here

To contact the reporter on this story:
Zac Fleming in New York at [email protected]

To contact the editor responsible for this story: ...

Learn more about a Bloomberg Law subscription.

Read Full Story: https://news.bloomberglaw.com/health-law-and-business/fda-authorizes-first-dt...